Japan to undertake iPS cell trials in coming years

06/25/2009 | Breitbart.com

Japan reportedly is planning within five years to conduct clinical trials on induced pluripotent stem cells aimed at producing retinal pigment epithelial cells to cure age-related macular degeneration and hematopoietic stem cells to treat blood conditions, among other treatments. The plan also calls for the creation of an iPS cell bank within two years.

View Full Article in:

Breitbart.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC